Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside

References

• Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF, Fairlie DW, Breit SN, Paralkar VM, de Tribolet N, Van Meir EG, Hegi ME. (2002). Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21:4212–4219.
   PubMed Web of Science ®Google Scholar
• Appierto V, Tiberio P, Villani MG, Cavadini E, Formelli F. (2009). PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation. Carcinogenesis 30:824–831.
   PubMed Web of Science ®Google Scholar
• Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman R, Maxwell PH, Choi P. (2010). Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 95:505–508.
   PubMed Web of Science ®Google Scholar
• Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE. (2004). Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 279:6883–6892.
   PubMed Web of Science ®Google Scholar
• Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J, Eling TE. (2005). Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol 67:356–364.
   PubMed Web of Science ®Google Scholar
• Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ, Johnen H, Russell PJ, Barret W, Stricker PD, Grygiel JJ, Kench JG, Henshall SM, Sutherland RL, Breit SN. (2005). The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res 65:2330–2336.
   PubMed Web of Science ®Google Scholar
• Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M, Breit SN. (2006). Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 66:4983–4986.
   PubMed Web of Science ®Google Scholar
• Bjørnstad JL, Neverdal NO, Vengen OA, Knudsen CW, Husebye T, Pepper J, Lie M, Christensen G, Tønnessen T. (2008). Alterations in circulating activin A, GDF-15, TGF-beta3 and MMP-2, -3, and -9 during one year of left ventricular reverse remodelling in patients operated for severe aortic stenosis. Eur J Heart Fail 10:1201–1207.
   PubMed Web of Science ®Google Scholar
• Bonaca MP, Morrow DA, Braunwald E, Cannon CP, Jiang S, Breher S, Sabatine MS, Kempf T, Wallentin L, Wollert KC. (2011). Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol 31:203–210.
   PubMed Web of Science ®Google Scholar
• Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN. (1997). MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94:11514–11519.
   PubMed Web of Science ®Google Scholar
• Böttner M, Laaff M, Schechinger B, Rappold G, Unsicker K, Suter-Crazzolara C. (1999). Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). Gene 237:105–111.
   PubMed Web of Science ®Google Scholar
• Cekanova M, Lee SH, Donnell RL, Sukhthankar M, Eling TE, Fischer SM, Baek SJ. (2009). Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice. Cancer Prev Res (Phila) 2:450–458.
   PubMed Web of Science ®Google Scholar
• Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC, Webber D, Kinahan T, Sadar M, Gleave ME, Vielkind J. (2004). Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 64:5929–5933.
   PubMed Web of Science ®Google Scholar
• Chen YL, Lin PC, Chen SP, Lin CC, Tsai NM, Cheng YL, Chang WL, Lin SZ, Harn HJ. (2007). Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells. J Pharmacol Exp Ther 323:746–756.
   PubMed Web of Science ®Google Scholar
• de Jager SC, Bermúdez B, Bot I, Koenen RR, Bot M, Kavelaars A, de Waard V, Heijnen CJ, Muriana FJ, Weber C, van Berkel TJ,Kuiper J, Lee SJ, Abia R, Biessen EA. (2011). Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J Exp Med. Available from: http://jem.rupress.org/content/early/2011/01/12/jem.20100370.long.
   PubMed Web of Science ®Google Scholar
• Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P, Bing C. (2009). Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 150:1688–1696.
   PubMed Web of Science ®Google Scholar
• Dostálová I, Roubícek T, Bártlová M, Mráz M, Lacinová Z, Haluzíková D, Kaválková P, Matoulek M, Kasalicky M, Haluzík M. (2009). Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur J Endocrinol 161:397–404.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Kempf T, Allhoff T, Lindahl B, Wallentin L, Wollert KC. (2008). Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J 29:2327–2335.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Jantzen F, Peter T, Allhoff T, Siegbahn A, Venge P, Wollert KC, Wallentin L. (2010). Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome. Circ Cardiovasc Genet 3:88–96.
   PubMed Web of Science ®Google Scholar
• Ferrari N, Pfeffer U, Dell’Eva R, Ambrosini C, Noonan DM, Albini A. (2005). The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Clin Cancer Res 11:4610–4619.
   PubMed Web of Science ®Google Scholar
• Foley PW, Stegemann B, Ng K, Ramachandran S, Proudler A, Frenneaux MP, Ng LL, Leyva F. (2009). Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. Eur Heart J 30:2749–2757.
   PubMed Web of Science ®Google Scholar
• Heger J, Schiegnitz E, von Waldthausen D, Anwar MM, Piper HM, Euler G. (2010). Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes. J Cell Physiol 224:120–126.
   PubMed Web of Science ®Google Scholar
• Huang CY, Beer TM, Higano CS, True LD, Vessella R, Lange PH, Garzotto M, Nelson PS. (2007). Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15. Clin Cancer Res 13:5825–5833.
   PubMed Web of Science ®Google Scholar
• Huh SJ, Chung CY, Sharma A, Robertson GP. (2010). Macrophage inhibitory cytokine-1 regulates melanoma vascular development. Am J Pathol 176:2948–2957.
   PubMed Web of Science ®Google Scholar
• Jang TJ, Kang HJ, Kim JR, Yang CH. (2004). Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Carcinogenesis 25:1853–1858.
   PubMed Web of Science ®Google Scholar
• Kadara H, Schroeder CP, Lotan D, Pisano C, Lotan R. (2006). Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis. Cancer Biol Ther 5:518–522.
   PubMed Web of Science ®Google Scholar
• Karan D, Holzbeierlein J, Thrasher JB. (2009). Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer. Cancer Res 69:2–5.
   PubMed Web of Science ®Google Scholar
• Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H, Wollert KC. (2006). The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98:351–360.
   PubMed Web of Science ®Google Scholar
• Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. (2007a). Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50:1054–1060.
   PubMed Web of Science ®Google Scholar
• Kempf T, Björklund E, Olofsson S, Lindahl B, Allhoff T, Peter T, Tongers J, Wollert KC, Wallentin L. (2007b). Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J 28:2858–2865.
   PubMed Web of Science ®Google Scholar
• Kempf T, Horn-Wichmann R, Brabant G, Peter T, Allhoff T, Klein G, Drexler H, Johnston N, Wallentin L, Wollert KC. (2007c). Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem 53:284–291.
   PubMed Web of Science ®Google Scholar
• Kempf T, Sinning JM, Quint A, Bickel C, Sinning C, Wild PS, Schnabel R, Lubos E, Rupprecht HJ, Münzel T, Drexler H, Blankenberg S, Wollert KC. (2009a). Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study. Circ Cardiovasc Genet 2:286–292.
   PubMed Web of Science ®Google Scholar
• Kempf T, Wollert KC. (2009b). Growth differentiation factor-15: a new biomarker in cardiovascular disease. Herz 34:594–599.
   PubMed Web of Science ®Google Scholar
• Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL. (2009). Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J 30:1057–1065.
   PubMed Web of Science ®Google Scholar
• Kim KS, Baek SJ, Flake GP, Loftin CD, Calvo BF, Eling TE. (2002). Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology 122:1388–1398.
   PubMed Web of Science ®Google Scholar
• Kim KK, Lee JJ, Yang Y, You KH, Lee JH. (2008a). Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 29:704–712.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim KY, Jeon JH, Lee SH, Hwang JE, Lee JH, Kim KK, Lim JS, Kim KI, Moon EY, Lee HG, Ryu JH, Yang Y. (2008b). Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells. Cancer Lett 261:253–262.
   Web of Science ®Google Scholar
• Kim JH, Chang JH, Rhee KH, Yoon JH, Kwon SH, Song K, Lee KW, Cho CI, Jeon JH, Kim KS. (2008c). Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene. Int J Cancer 122:1765–1773.
   PubMed Web of Science ®Google Scholar
• Kim MY, Moon JY, Hwang JW, Lee SY, Joo YM, Han SI, Park HG, Kang HS. (2008d). Implication of NAG-1 in synergistic induction of apoptosis by combined treatment of sodium salicylate and PI3K/MEK1/2 inhibitors in A549 human lung adenocarcinoma cells. Biochem Pharmacol 75:1751–1760.
   PubMed Web of Science ®Google Scholar
• Lankeit M, Kempf T, Dellas C, Cuny M, Tapken H, Peter T, Olschewski M, Konstantinides S, Wollert KC. (2008). Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med 177:1018–1025.
   PubMed Web of Science ®Google Scholar
• Lee SH, Yamaguchi K, Kim JS, Eling TE, Safe S, Park Y, Baek SJ. (2006). Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 27:972–981.
   PubMed Web of Science ®Google Scholar
• Lee SH, Krisanapun C, Baek SJ. (2010). NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta and ATF3. Carcinogenesis 31:719–728.
   PubMed Web of Science ®Google Scholar
• Lim JH, Park JW, Min DS, Chang JS, Lee YH, Park YB, Choi KS, Kwon TK. (2007). NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 12:411–421.
   PubMed Web of Science ®Google Scholar
• Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B, Olofsson S, Venge P, Larsson A, Hulthe J, Elmgren A, Wollert KC. (2009). Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Eur Heart J 30:2346–2353.
   PubMed Web of Science ®Google Scholar
• Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ, Breit SN, Panhurst S. (2003). Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 63:5034–5040.
   PubMed Web of Science ®Google Scholar
• Meadows CA, Risbano MG, Zhang L, Geraci MW, Tuder RM, Collier DH, Bull TM. (2010). Increased expression of growth differentiation factor-15 in scleroderma-associated pulmonary arterial hypertension. Chest. Available from: http://chestjournal.chestpubs.org/content/early/2010/09/07/chest.10-0302.long.
   PubMed Web of Science ®Google Scholar
• Nickel N, Kempf T, Tapken H, Tongers J, Laenger F, Lehmann U, Golpon H, Olsson K, Wilkins MR, Gibbs JS, Hoeper MM, Wollert KC. (2008). Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178:534–541.
   PubMed Web of Science ®Google Scholar
• Pang RP, Zhou JG, Zeng ZR, Li XY, Chen W, Chen MH, Hu PJ. (2007). Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway. Cancer Lett 251:268–277.
   PubMed Web of Science ®Google Scholar
• Park JY, Park KH, Bang S, Kim MH, Koh SS, Song SY. (2008). Expression of nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) inversely correlates with tumor progression in gastric adenomas and carcinomas. J Cancer Res Clin Oncol 134:1029–1035.
   PubMed Web of Science ®Google Scholar
• Park YJ, Lee H, Lee JH. (2010). Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells. bmb Rep 43:91–96.
   PubMed Web of Science ®Google Scholar
• Piyanuch R, Sukhthankar M, Wandee G, Baek SJ. (2007). Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett 258:230–240.
   PubMed Web of Science ®Google Scholar
• Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, Metz J, Kinscherf R. (2004). Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 318:325–333.
   PubMed Web of Science ®Google Scholar
• Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK. (2010). Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene 29:1293–1302.
   PubMed Web of Science ®Google Scholar
• Shim M, Eling TE. (2005). Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. J Biol Chem 280:18636–18642.
   PubMedGoogle Scholar
• Shim M, Eling TE. (2008). Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism. Mol Cancer Ther 7:961–971.
   PubMed Web of Science ®Google Scholar
• Stahrenberg R, Edelmann F, Mende M, Kockskämper A, Düngen HD, Lüers C, Binder L, Herrmann-Lingen C, Gelbrich G, Hasenfuss G, Pieske B, Wachter R. (2010). The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction. Eur J Heart Fail 12:1309–1316.
   PubMed Web of Science ®Google Scholar
• Stejskal D, Karpísek M, Humenanská V, Lacnák B, Svesták M. (2009). Macrophage-inhibitory cytokine-1 (mic-1) in differential diagnosis of dyspnea–a pilot study. Clin Biochem 42:1347–1351.
   PubMed Web of Science ®Google Scholar
• Strelau J, Strzelczyk A, Rusu P, Bendner G, Wiese S, Diella F, Altick AL, von Bartheld CS, Klein R, Sendtner M, Unsicker K. (2009). Progressive postnatal motoneuron loss in mice lacking GDF-15. J Neurosci 29:13640–13648.
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Strelau J, Unsicker K. (2003). Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways. J Biol Chem 278:8904–8912.
   PubMed Web of Science ®Google Scholar
• Sun T, Huang Y, Phillips MI, Luo X, Zhu J, Shi H, Li J. (2010). Growth differentiation factor 15 and coronary collateral formation. Clin Cardiol 33:E1–E5.
   PubMedGoogle Scholar
• Ago T, Sadoshima J. (2006). GDF15, a cardioprotective TGF-β superfamily protein. Circ Res 98:294–297.
   PubMed Web of Science ®Google Scholar
• Wang F, Guo Y, Yu H, Zheng L, Mi L, Gao W. (2010). Growth differentiation factor 15 in different stages of heart failure: potential screening implications. Biomarkers 15:671–676.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang X, Sun K, Chen J, Song X, Wang H, Liu Z, Wang C, Zhang C, Hui R. (2010). The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. Clin Sci 118:137–145.
   Web of Science ®Google Scholar
• Wang Y, Yu H, Xu M, Gao W. (2010). Expression and significance of growth differentiation factor-15 in myocardial fibroblast. Chin J Med Guide 12:633–635.
   Google Scholar
• Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L. (2007a). Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 115:962–971.
   PubMed Web of Science ®Google Scholar
• Wollert KC, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T, Peter T, Siegbahn A, Venge P, Drexler H, Wallentin L. (2007b). Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 116:1540–1548.
   PubMed Web of Science ®Google Scholar
• Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. (2006). GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342–350.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Lee SH, Eling TE, Baek SJ. (2004). Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway. j Biol Chem 279:49617–49623.
   PubMed Web of Science ®Google Scholar
• Yang H, Filipovic Z, Brown D, Breit SN, Vassilev LT. (2003). Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2:1023–1029.
   PubMed Web of Science ®Google Scholar
• Yang H, Choi HJ, Park SH, Kim JS, Moon Y. (2009). Macrophage inhibitory cytokine-1 (MIC-1) and subsequent urokinase-type plasminogen activator mediate cell death responses by ribotoxic anisomycin in HCT-116 colon cancer cells. Biochem Pharmacol 78:1205–1213.
   PubMed Web of Science ®Google Scholar
• Zimmers TA, Gutierrez JC, Koniaris LG. (2010). Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer. J Cancer Res Clin Oncol 136:571–576.
   PubMed Web of Science ®Google Scholar